-
公开(公告)号:US20160279107A1
公开(公告)日:2016-09-29
申请号:US15178579
申请日:2016-06-10
申请人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Xinzhong LAI , Philipp LUSTENBERGER , Bernd Ulrich RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang Wu , Jianguang ZHOU
发明人: Jun CAO , Bernhard ERB , Robin Alec FAIRHURST , Arnaud GRANDEURY , Shinji HATAKEYAMA , Magdalena KOZICZAK-HOLBRO , Xinzhong LAI , Philipp LUSTENBERGER , Bernd Ulrich RIEBESEHL , Nicola TUFILLI , Thomas ULLRICH , Xiang Wu , Jianguang ZHOU
IPC分类号: A61K31/428
CPC分类号: A61K31/428 , A61K31/167 , A61K45/06 , C07B2200/07 , C07C53/10 , C07D277/68 , Y02P20/55
摘要: The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.
摘要翻译: 制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。